Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Rheumatology Unit, L. Sacco Hospital, Milan, Italy.
A double-blind, placebo-controlled study of the efficacy and tolerability of 5-hydroxytryptophan (5-HTP) was conducted in 50 patients with primary fibromyalgia syndrome. All the clinical parameters studied were significantly improved by treatment with 5-HTP and only mild and transient side-effects were reported. Further controlled studies are required to define properly the value of 5-HTP in patients with primary fibromyalgia syndrome.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on